Overview

GLP-1R Actions on Muscle and the Skeleton

Status:
NOT_YET_RECRUITING
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The GRAMS study objectives are to assess the musculoskeletal changes that occur after weight loss using GLP-1 based therapy. A lifestyle intervention with diet and exercise is included to assess any mitigating effects are provided, versus a control group with regular exercise and diet.
Phase:
PHASE3
Details
Lead Sponsor:
Pennington Biomedical Research Center
Treatments:
Tirzepatide